-- Q3M Arm Demonstrated 95% Mean Monthly Attack-Rate Reduction -- -- Q6M Arm Demonstrated 86% Mean Monthly Attack-Rate Reduction – -- Well-Tolerated with a Favorable Safety Profile -- -- All Patients ...